Neos Therapeutics resubmits ADHD drug marketing application
Reuters Drug developer Neos Therapeutics Inc said on Tuesday it resubmitted the marketing application for its attention deficit/hyperactivity disorder (ADHD) drug to the U.S. Food and Drug Administration. The company said last year the FDA had identified ... |
December 20, 2016 at 10:14AM | marketing - Google News
Neos Therapeutics resubmits ADHD drug marketing application - Reuters
marketing - Google News
Nenhum comentário:
Postar um comentário